Company news

Guangdong Provincial Yueke Master Fund and New Value Capital Sign a Strategic Cooperation Framework Agreement

10

2021/06

Guangdong Provincial Yueke Master Fund and New Value Capital Sign a Strategic Cooperation Framework Agreement

New Value Capital was awarded the Best Equity Investment Institution in China in 2021, and Dr. Jia Junxin, Chairman of New Value, was awarded the Person of the Year in Equity Investment in China

28

2021/04

New Value Capital was awarded the Best Equity Investment Institution in China in 2021, and Dr. Jia Junxin, Chairman of New Value, was awarded the Person of the Year in Equity Investment in China

New Value Capital participates in the first round of financing for AI innovative pharmaceutical enterprise Alpha molecule incubated by advanced institutes

15

2021/04

New Value Capital participates in the first round of financing for AI innovative pharmaceutical enterprise Alpha molecule incubated by advanced institutes

New Value Capital was awarded the Top 30 Best Healthcare Investment Institution in China in 2020&Top 10 Growth VC Investment Institution in China in 2020

12

2020/12

New Value Capital was awarded the Top 30 Best Healthcare Investment Institution in China in 2020&Top 10 Growth VC Investment Institution in China in 2020

Dr. Jia Junxin from NewValue Capital was invited to attend the 2020 China Changde Biomedical Health Industry Development Conference!

19

2020/11

Dr. Jia Junxin from NewValue Capital was invited to attend the 2020 China Changde Biomedical Health Industry Development Conference!

Huanchuang Technology, an enterprise invested by New Value Capital, has been selected on the KPMG China "Core Technology" Emerging Enterprise 50 List

12

2020/11

Huanchuang Technology, an enterprise invested by New Value Capital, has been selected on the KPMG China "Core Technology" Emerging Enterprise 50 List

Warm congratulations on the listing of the cutting-edge biotechnology innovation board invested by New Value Capital!

29

2020/10

Warm congratulations on the listing of the cutting-edge biotechnology innovation board invested by New Value Capital!

Good news: The first AIDS drug project in China invested by New Value Capital - Frontier Biotechnology Innovation Board IPO was successful

08

2020/08

Good news: The first AIDS drug project in China invested by New Value Capital - Frontier Biotechnology Innovation Board IPO was successful

Qiyu Biotechnology (Shanghai) Co., Ltd., a research and development company focused on innovative macromolecular biopharmaceuticals

29

2020/07

Qiyu Biotechnology (Shanghai) Co., Ltd., a research and development company focused on innovative macromolecular biopharmaceuticals

< 1 2 3 4 5 6 >

Address：4608, Rongchao Economic and Trade Center, 4028 Jintian Road, Futian District, Shenzhen

Tel: 86-0755-83718558

Fax: 86 -0755 -83717558

Email: xhld@cnxhld.com

Human Resources

Copyright ©2023 Shenzhen New Value Capital Management Co.,Ltd.

Business License

SEO Technical Support: China Enterprise Power Shenzhen